Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 2966Carcinoma, Renal Cell 883Urinary Bladder Neoplasms 712Kidney Neoplasms 457Breast Neoplasms 408Neoplasms 390Neoplasm Metastasis 229Carcinoma, Non-Small-Cell Lung 229Lung Neoplasms 216Ovarian Neoplasms 211Colorectal Neoplasms 204Melanoma 195Carcinoma, Transitional Cell 190Testicular Neoplasms 171Pancreatic Neoplasms 142Sarcoma 129Head and Neck Neoplasms 121Colonic Neoplasms 120Wilms Tumor 119Uterine Cervical Neoplasms 116Stomach Neoplasms 98Neuroblastoma 90Multiple Myeloma 88Lymphoma, Non-Hodgkin 86Esophageal Neoplasms 86Lymphoma 83Carcinoma, Hepatocellular 81Carcinoma, Ovarian Epithelial 80Recurrence 75Squamous Cell Carcinoma of Head and Neck 74

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Amyotrophic Lateral Sclerosis × Genitourinary × Clear all
NCT03516994 2024-05-16

EQUALACP

Duke University

Phase NA Completed
790 enrolled
Genitourinary

Amyotrophic Lateral Sclerosis, Heart Failure, Kidney Failure, Chronic, Neoplasm Metastasis, Parkinson Disease, Lung Diseases, Interstitial, Pulmonary Disease, Chronic Obstructive, Diabetes Complications, End Stage Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡